LENZ Therapeutics share price logo

LENZ Therapeutics

NASDAQ: LENZ

$4.47

-0.05

(-1.11%)

as on

LENZ Therapeutics Stock Performance

as on September 15, 2026 at 2:16 pm IST

  • Day's Low

    Day's High

    $4.42
    $4.60
    downward going graph

    1.12%

    Downside

    2.91%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $4.42
    $50.40
    downward going graph

    1.12%

    Downside

    1027.52%

    Upside

    downward going graph

LENZ Therapeutics share price movements today

Previous Close
$4.52
Open
$4.53
Volume
848.1K
Market Cap
$142.0M
Day's Low - High
$4.42 - $4.60
52 Week Low - High
$4.42 - $50.40

LENZ Therapeutics Historical Returns

1 Month Return
-5.5 %
3 Month Return
-32.58 %
1 Year Return
-88.83 %
3 Year Return
0 %
5 Year Return
0 %

LENZ Therapeutics Stock Fundamentals & Key Indicators

Check LENZ Therapeutics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$142.0M

EPS (TTM)

-4.09

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-1.12

Industry PE ratio

-1.78

PEG Ratio

0.017827512949521132

EBITDA

-125.5M

Revenue (TTM)

21.5M

Profit Margin

90.14%

Return On Equity TTM

-53.39%

LENZ Therapeutics Stock Valuation

Track how LENZ Therapeutics P/E has moved over time to understand its valuation trends.

LENZ Therapeutics in the last 5 years

  • Overview

  • Trends

Lowest (-12.34x)

December 31, 2024

Today (-5.61x)

December 31, 2025

Industry (-1.78x)

December 31, 2025

Highest (-1.44x)

December 31, 2023

LowHigh

Today’s Price to Earnings Ratio: -5.61x

LENZ Therapeutics vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of LENZ Therapeutics with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
BUY$142.0MNA-1.1290.14%NA
BUY$44.6B614.61%NA0.00%NA
BUY$130.6B175.08%29.7686.04%NA
BUY$57.5B-66.24%-18.04-12.57%NA
BUY$80.5B21.74%18.9584.86%47.339999999999996%

Stock Returns calculator for LENZ Therapeutics Stock including INR - Dollar returns

The LENZ Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

LENZ Therapeutics investment value today

Current value as on today

₹12,113

Returns

-₹87,887

(-87.89%)

Returns from LENZ Therapeutics Stock

-₹88,828 (-88.83%)

Dollar Impact

₹940 (+0.94%)

Analyst Recommendation on LENZ Therapeutics Stock

Based on 6 analysts

BUY

66.67%

Buy

33.33%

Hold

0.00%

Sell

Based on 6 analysts, 66.66666666666666% of analysts recommend a 'BUY' rating for LENZ Therapeutics. Average target price of $24

LENZ Therapeutics Share Price Target

Get share price movements and forecasts by analysts on LENZ Therapeutics.

What analysts predicted

81.38%UPSIDE

Target Price

$24

Current Price

$4.47

Analyzed by

6 Analysts

Target

$24.00

LENZ Therapeutics target price $24, a slight upside of 81.38% compared to current price of $4.47. According to 6 analysts rating.

Indian Investors' Interest in LENZ Therapeutics Stock

Search interest for LENZ Therapeutics Stock has decreased by -2% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-2% versus previous 30 day period

LENZ Therapeutics Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
-
-
-
-
-
5
12
1
1
5
Gross Profit
-
-
-
-
0
4
12
1
0
5
Operating Income
-16
-14
-12
-15
-16
-16
-18
-38
-44
-34
EBITDA
-16
-10
-10
-12
-14
-14
-16
-35
-41
-31
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-16
-10
-10
-12
-14
-14
-16
-35
-41
-31
Income Tax Expense
-
-
-
0
-
0
-
0
-
0
Net Income
-16
-10
-10
-12
-14
-14
-16
-35
-41
-31
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
99.62%
99.00%
66.94%
37.56%
94.90%

LENZ Therapeutics Annual Profit & Loss

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
15
-
-
19
Gross Profit
-
0
0
15
-
0
18
Operating Income
0
-13
-60
-10
-72
-58
-91
EBITDA
0
-68
-70
-10
-70
-49
-81
Interest Expense
0
0
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
Income Before Tax
0
-68
-70
-10
-70
-49
-81
Income Tax Expense
-
-
-
0
0
0
0
Net Income
0
-68
-70
-10
-69
-49
-82
Net Profit Margin
0.00%
0.00%
0.00%
100.00%
0.00%
0.00%
96.31%

LENZ Therapeutics Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-16
-10
-10
-12
-14
-14
-16
-35
-41
-31
Operating Cash Flow
-23
-15
-10
-9
-16
-11
-8
-33
-33
-38
Investing Cash Flow
18
-98
-62
-11
18
0
-4
-89
33
37
Financing Cash Flow
171
-2
29
0
0
26
0
122
0
0
Change in Cash
165
-116
-42
-20
2
14
-12
0
0
0

LENZ Therapeutics Annual Cash Flow

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
0
-68
-70
-101
-69
-49
-82
Operating Cash Flow
0
-8
-52
-87
-60
-59
-69
Investing Cash Flow
-
-1
-5
-241
-29
-154
-75
Financing Cash Flow
-
30
417
0
80
199
149
Change in Cash
0
19
357
-329
-9
-14
4

Mutual Funds that own LENZ Therapeutics Stock

Check out the Mutual Funds with significant holdings in LENZ Therapeutics.

Funds
Holdings
Shares Held
Fidelity Mt. Vernon Street Trust
6.072097%
1907874
VANGUARD INDEX FUNDS
3.234057%
1016152
PRIMECAP Odyssey Funds
1.293429%
406400
Franklin Strategic Series
1.090147%
342528
Fidelity Concord Street Trust
0.718601%
225787

Global Institutional Holdings in LENZ Therapeutics

Funds
Holdings
Schwab
0.44%
Peter Kolchinsky
13.3%
Richard Gerson
11.5%
Brad Bolzon
8.46%
Vanguard
4.02%

LENZ Therapeutics News & Key Events

  • img

    Today's Timeline - 30 September

    Tue, 07:04 PM

    -

    Lenz Therapeutics announces VIZZ eye drops are now available in the U.S. for presbyopia treatment.

Insights on LENZ Therapeutics

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 514.3% return, outperforming this stock by 603.1%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, LENZ stock has moved down by -16.1%

About LENZ Therapeutics

LENZ Therapeutics, Inc. operates as a commercial pharmaceutical company that focuses on the development and commercialization of therapies to improve vision in the United States. Its product candidates include VIZZ and LNZ101 for the treatment of presbyopia in adults. LENZ Therapeutics, Inc. was formerly known as Presbyopia Therapies, Inc. and changed its name to LENZ Therapeutics, Inc. in June 2021. The company was founded in 2013 and is headquartered in Solana Beach, California.
OrganisationLENZ Therapeutics
Headquarters201 Lomas Santa Fe Drive, Solana Beach, CA, United States, 92075
IndustryBiotechnology
CEOMr. Evert B. Schimmelpennink
E-voting on sharesClick here to vote

Key Management of LENZ Therapeutics

Name

Title

Mr. Evert B. Schimmelpennink

President, CEO, Secretary & Director

Mr. James W. McCollum

Co-Founder & Director

Mr. Marc G. Odrich M.D.

Chief Medical Officer

Mr. Daniel R. Chevallard CPA

Chief Financial Officer

Ms. Melissa Rosness

Senior Vice President of Manufacturing Operations

Kris Gambelin

Senior Vice President of Regulatory & Clincal Operations

Mr. Shawn Olsson

Chief Commercial Officer

Mr. Domenick Porfidia

Vice President of Sales

Mr. David Choromanski

Vice President of Marketing

FAQs

What is LENZ Therapeutics share price today?

LENZ Therapeutics share price today is $4.47 as on at the close of the market. LENZ Therapeutics share today touched a day high of $4.60 and a low of $4.42.

What is the 52 week high and 52 week low for LENZ Therapeutics share?

LENZ Therapeutics share touched a 52 week high of $50.40 on and a 52 week low of $4.42 on . LENZ Therapeutics stock price today i.e. is closed at $4.47,which is 91.13% down from its 52 week high and 1.13% up from its 52 week low.

What is LENZ Therapeutics's market capitalisation today?

LENZ Therapeutics market capitalisation is $0.00T as on .

How to invest in LENZ Therapeutics Stock (LENZ) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for LENZ Therapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in LENZ Therapeutics Shares that will get you 0.3356 shares as per LENZ Therapeutics share price of $4.47 per share as on September 15, 2026 at 8:46 am IST.

What is the minimum amount required to buy LENZ Therapeutics Stock (LENZ) from India?

Indian investors can start investing in LENZ Therapeutics (LENZ) shares with as little as ₹95.54 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹955.40 in LENZ Therapeutics stock (as per the Rupee-Dollar exchange rate as on ). Based on LENZ Therapeutics share’s latest price of $4.47 as on September 15, 2026 at 8:46 am IST, you will get 2.2371 shares of LENZ Therapeutics. Learn more about fractional shares .